You are currently viewing DES in Bifurcation Lesions insight from the ICPS Registry

DES in Bifurcation Lesions insight from the ICPS Registry

DES in Bifurcation Lesions insight from the ICPS Registry

European Bifurcation Club 2007, EBC 2007 – Valencia, Spain

NEW DEVICES, NEW TECHNIQUES

DES in Bifurcation Lesions insight from the ICPS Registry

Author: Thierry Lefevre, MD, ICPS, France

 

STUDY

  • Prospective registry (2003-2005)
  • All consecutive DES patients
  • Provisonal SB T-stenting strategy
  • Clinical follow-up at 6, 12 months and 2 years
  • Angiography in case of ischaemia
  • Aspirin ≥75 mg/d, indefinitely
  • Clopidogrel 75 to 150 mg/d > 2/6 months (Cypher/Taxus)

CONCLUSION

In this large real world prospective multicenter study on bifurcation lesions stenting using a predefined strategy of provisional SB T-stenting, we found that this approach can be used in about90% of cases. We found very promising results up to 2 years.

The risk of stent thrombosis remains acceptablecompared to non bifurcation lesions. The only independant procedural predictor of death is the non use of a provisional SB T-stenting strategy. However, there is probably confounding factors.

 

Download here

Leave a Reply